Delivery Order SPE2DB20D1100-SPE2DB25FC0N8
Award Date
5/1/25
Potential Completion Date
5/22/25
Potential Value
$12K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,115.58, is for the delivery of TESTOPEL 75 MG PELLETS 100S medical supplies. The contract is a firm fixed-price delivery order that runs through May 5, 2025. It is not associated with any set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of TESTOPEL 75 MG PELLETS 100S, a pharmaceutical product, with a ceiling value of $11,934.27. The contract is a firm fixed-price delivery order and does not have a set-aside designation. AmerisourceBergen is the prime contractor, and the contract has an ultimate completion date of September 13, 2024. This...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TESTOPEL 75 MG PELLETS 100S, with a ceiling value of $4,115.58 and a performance period through March 11, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Additionally, AmerisourceBergen Drug Corp holds a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,115.58 firm-fixed-price contract is for the delivery of TESTOPEL 75 MG PELLETS 100S, a medical product, with a performance period through May 28, 2025. The contract is not set aside for any particular business type. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,115.58, is for the provision of TESTOPEL 75 MG PELLETS 100S, a pharmaceutical product. The contract has a completion date of February 27, 2025 and is a firm fixed-price delivery order contract. This contract is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TESTOPEL 75 MG PELLETS 10S, a medical product, with a ceiling value of $9,877.44 and a performance period ending on July 15, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract...
This is a $4,115.58 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TESTOPEL 75 MG PELLETS 100S, a pharmaceutical product, with a performance period ending on July 21, 2025. The contract is not set aside and was awarded on June 27, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $3,978.09 contract is for the supply of TESTOPEL 75 MG PELLETS 100S, a medical product, with a period of performance through August 13, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of TESTOPEL 75 MG PELLETS 100S. The contract has a ceiling value of $12,346.74 and a performance period ending on February 11, 2025. It is a firm-fixed-price contract, and there is no set-aside designation indicated. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This is a $4,115.58 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TESTOPEL 75 MG PELLETS 100S, a pharmaceutical product, with a period of performance through July 1, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00...